High-Intensity Interval Training (HIIT) for Parkinson's Disease
Also known as: HIIT, High-intensity exercise, Sprint interval training
High-intensity exercise is the only intervention shown to potentially slow Parkinson's disease progression.
Mechanism of Action
HIIT drives BDNF-dependent neuroplasticity in basal ganglia, enhances dopamine signaling efficiency, promotes mitochondrial biogenesis in remaining dopaminergic neurons, and reduces neuroinflammation. Forced exercise at high intensity may uniquely benefit PD through motor learning circuits.
General mechanism: High-intensity cardiovascular stress. BDNF/irisin release, PGC-1α activation, NK cell mobilization, insulin sensitization, angiogenesis.
Current Evidence
SPARX trial showed high-intensity treadmill exercise (80-85% max HR) significantly slowed UPDRS decline vs usual care. Study to Protect and Assess Research with Exercise (SPARX2) is confirmatory.
Clinical Status: Phase III (SPARX) positive. High-intensity exercise recommended by MDS.
Safety Profile
Generally safe when appropriately prescribed. Cardiac screening recommended for sedentary individuals. Adapt to patient capacity. ALS: moderate intensity preferred.
Key Research Questions
- Can HIIT slow PD progression as measured by DaTscan?
- What exercise intensity threshold is needed for disease modification?